Transdermal patch with Hydrogel Technology
IBSA’s unique technological innovations have led to the creation and production of medicated patches in its systems, both single-layer and multi-layer, designed to act locally or systemically, depending on the location of action of the active ingredient.
With Hydrogel technology, the topical patch is capable of releasing a drug in a controlled manner for periods of time ranging from a few hours to a week, which offers several advantages over oral administration, which include maintaining optimal drug concentrations, reducing frequency of administration, and increasing tolerability.
Hydrogel Technology is active on the pain and gentle on the skin.
Want to know more about the technology?
Contact usWant to know who is IBSA?
DISCOVER MOREHYDROGEL TECHNOLOGY: A FAST AND TARGETED ACTION AGAINST PAIN AND INFLAMMATION.
Do you want to know more?
Fill the form to contact us
IBSA Business Development
Since 2018, there has been a new Department in IBSA fully dedicated to Business Development, Licensing activities and CDMO projects. Licensing The Business Development Dept. is constantly looking for partners and international distributors for licensing agreements in countries where IBSA does not operate directly with its branches. IBSA is focused on strategic collaborations to achieve a common goal while sharing responsibilities, resources, risks and rewards. Close ties with local distributors are crucial for IBSA to grow at an international level. The Business Development Dept. also evaluates licensing-in opportunities for the expansion of product portfolio.